Literature DB >> 22449768

The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.

Melina Fatseas1, Romain Debrabant, Marc Auriacombe.   

Abstract

PURPOSE OF REVIEW: Adult attention deficit/hyperactivity disorder (ADHD) is a common comorbid condition to substance use disorder (SUD) and is associated with worse prognosis and quality of life. This review summarizes recent work assessing ADHD diagnosis reliability in SUD patients and provides arguments to enhance the accuracy of detecting this disorder. RECENT
FINDINGS: Adequate diagnosis of ADHD in SUD patients is challenged by phenomenological aspects of addiction and frequently associated other psychiatric disorders that overlap with key symptoms of ADHD. A detailed comprehensive search for child and adult symptoms including the temporal relationship of ADHD, substance use and other psychiatric disorders should maximize the validity and the reliability of adult ADHD diagnosis in this population. Further, a follow-up evaluation of ADHD symptoms during treatment of SUD may reduce the likelihood of misdiagnosis.
SUMMARY: Considering the high rate of ADHD comorbidity among SUD patients, it is crucial to promote a systematic diagnostic approach to this disorder in specialized addiction treatment settings. However, overlapping symptoms between disorders frequently challenge the accuracy of adult ADHD diagnosis. Areas in need of further investigations include the development of valid screening procedures, associated neuropsychological factors and effective treatment strategies for these populations.

Entities:  

Mesh:

Year:  2012        PMID: 22449768     DOI: 10.1097/YCO.0b013e3283523d7c

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  12 in total

1.  The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population.

Authors:  Geurt van de Glind; Katelijne Van Emmerik-van Oortmerssen; Pieter Jan Carpentier; Frances R Levin; Maarten W J Koeter; Csaba Barta; Sharlene Kaye; Arvid Skutle; Johan Franck; Maija Konstenius; Eli-Torild Bu; Franz Moggi; Geert Dom; Zolt Demetrovics; Mélina Fatséas; Arild Schillinger; Máté Kapitány-Fövény; Sofie Verspreet; Andrea Seitz; Brian Johnson; Stephen V Faraone; J Antoni Ramos-Quiroga; Steve Allsop; Susan Carruthers; Robert A Schoevers; Wim van den Brink
Journal:  Int J Methods Psychiatr Res       Date:  2013-09-11       Impact factor: 4.035

Review 2.  Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?

Authors:  Pieter-Jan Carpentier; Frances R Levin
Journal:  Harv Rev Psychiatry       Date:  2017 Mar/Apr       Impact factor: 3.732

3.  International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

Authors:  Cleo L Crunelle; Wim van den Brink; Franz Moggi; Maija Konstenius; Johan Franck; Frances R Levin; Geurt van de Glind; Zsolt Demetrovics; Corné Coetzee; Mathias Luderer; Arnt Schellekens; Frieda Matthys
Journal:  Eur Addict Res       Date:  2018-03-06       Impact factor: 3.015

4.  Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs.

Authors:  Fabio Lugoboni; Frances Rudnick Levin; Maria Chiara Pieri; Matteo Manfredini; Lorenzo Zamboni; Lorenzo Somaini; Gilberto Gerra
Journal:  Psychiatry Res       Date:  2017-01-21       Impact factor: 3.222

5.  Feasibility of an Extensive Strategy for Adult Diagnosis of Attention Deficit Hyperactivity Disorder Among Patients Suffering From Substance Use Disorders.

Authors:  Norman Therribout; Emily Karsinti; Alix Morel; Alexandra Dereux; Florence Vorspan; Lucia Romo; Romain Icick
Journal:  Front Psychiatry       Date:  2022-06-28       Impact factor: 5.435

Review 6.  Cognitive characterization of adult attention deficit hyperactivity disorder by domains: a systematic review.

Authors:  Iban Onandia-Hinchado; Natividad Pardo-Palenzuela; Unai Diaz-Orueta
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575

Review 7.  Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.

Authors:  José Pérez de los Cobos; Núria Siñol; Víctor Pérez; Joan Trujols
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 8.  Male adolescent substance use disorder and attention-deficit hyperactivity disorder: a review of the literature.

Authors:  Robert Eme
Journal:  ISRN Addict       Date:  2012-11-28

9.  Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

Authors:  Kathleen A Fairman; Lindsay E Davis; Alyssa M Peckham; David A Sclar
Journal:  Drugs Real World Outcomes       Date:  2018-03

10.  Clinical, Psychopathological, and Personality Characteristics Associated with ADHD among Individuals Seeking Treatment for Gambling Disorder.

Authors:  N Aymamí; S Jiménez-Murcia; R Granero; J A Ramos-Quiroga; F Fernández-Aranda; L Claes; A Sauvaget; M Grall-Bronnec; M Gómez-Peña; L G Savvidou; A B Fagundo; A del Pino-Gutierrez; L Moragas; M Casas; E Penelo; J M Menchón
Journal:  Biomed Res Int       Date:  2015-07-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.